Top

Journal of Neurology

Published in:

01-04-2014 | Letter to the Editors

When myasthenia gravis is not all

Authors: V. Damato, P. E. Alboini, A. Mastrorosa, A. Dickmann, C. Colosimo, A. Evoli

Published in: Journal of Neurology | Issue 4/2014

Excerpt

Dear Sirs, …

Kupersmith MJ, Ying G (2005) Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment. Br J Ophthalmol 89:1330–1334PubMedCentralCrossRefPubMed

Cerman E, Esen F, Eraslan M, et al. Orbital myositis associated with celiac disease. Int Ophthalmol Epub 2013 Jul 11

Ssi-Yan-Kai I, Pearson A (2012) Orbital myositis and psoriatic arthritis. Can J Ophthalmol 47:42–43CrossRef

Okamoto K, Ito J, Tokiguchi S et al (1996) Atrophy of bilateral extraocular muscles. CT and clinic features of seven patients. J Neuroophthalmol 16:286–288PubMed

Chan JW, Orrison WW (2007) Ocular myasthenia: a rare presentation with MuSK antibody and bilateral extraocular muscle atrophy. Br J Ophthalmol 91:842–843PubMedCentralCrossRefPubMed

Zouvelou V, Rentzos M, Toulas P et al (2011) MRI evidence of early muscle atrophy in MuSK positive myasthenia gravis. J Neuroimaging 21(3):303–305CrossRefPubMed

Gordon LK (2006) Orbital inflammatory disease: a diagnostic and therapeutic challenge. Eye 20:1196–1206CrossRefPubMed

Title: When myasthenia gravis is not all
Authors: V. Damato
P. E. Alboini
A. Mastrorosa
A. Dickmann
C. Colosimo
A. Evoli
Publication date: 01-04-2014
Publisher: Springer Berlin Heidelberg
Published in: Journal of Neurology / Issue 4/2014
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-014-7307-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

When myasthenia gravis is not all

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2014

Seizure precipitants in a community-based epilepsy cohort

Unusual features of Creutzfeldt–Jakob disease followed-up in a memory clinic

Erratum to: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study

Selective retinal ganglion cell loss in familial dysautonomia

A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis

Clinical progression of SYNJ1-related early onset atypical parkinsonism: 3-year follow up of the original Italian family